TTM Capital was rated as one of the TOP 50 Early-Stage Venture Capital Institutions in China Dec.08.2023
TTM Capital was awarded two honors by China Bridge: China's Best Return Venture Capital Institution Jan.18.2024
TTM Family | Tosun Pharmaceutical Completes US$40 Million Angel Round to Accelerate Pipeline Development and Support Its Growth as a Leader in Innovative Oncology Therapies Feb.03.2026
TTM Capital Ranks on FOFWEEKLY's "2025 New-Quality Productivity Investment Institution Soft Power Ranking - Healthcare TOP 20" Sept.15.2025
